Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses RDNW Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction OS Therapies OSTX Q4 2025 Earnings WiderThanExpected Loss Weighs on Shares NNOX Q4 2025 Earnings EPS Misses Estimates PreRevenue Status Continues BOF Q1 2026 Earnings EPS Loss of 012 Amid Operational Challenges Leslies Inc Q1 2026 Earnings Significant EPS Miss Despite Strong Stock Rally